Inactive Instrument
Lotus Pharmaceuticals, Inc. Stock Other OTC
Stocks
LTUS
US5457152032
Pharmaceuticals
OTC Markets Traded| Market Cap | 9.74M 8.55M 7.95M 7.3M 13.71M 938M 13.92M 94.43M 36.89M 461M 36.55M 35.76M 1.59B | P/E 2009 |
3.88x | P/E 2010 | 4.84x |
|---|---|---|---|---|---|
| Enterprise Value | 14.38M 12.63M 11.75M 10.78M 20.25M 1.39B 20.57M 139M 54.5M 681M 53.99M 52.83M 2.35B | EV / Sales 2009 |
1.02x | EV / Sales 2010 | 0.95x |
| Free-Float |
99% | Yield 2009 * |
-
| Yield 2010 | - |
| 1 day | +41.51% |
| Manager | Title | Age | Since |
|---|---|---|---|
Georgene Rivers
CEO | Chief Executive Officer | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
Georgene Rivers
BRD | Director/Board Member | - | - |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +41.51% | -18.92% | - | - | 7.93M | |
| -0.66% | +0.44% | +14.72% | +76.40% | 48.36B | |
| +2.20% | +1.41% | +61.04% | +111.43% | 35.8B | |
| +1.26% | -0.57% | -5.20% | +34.48% | 11.83B | |
| -0.46% | -3.06% | +14.15% | +80.63% | 11.48B | |
| -0.37% | -0.37% | +37.89% | +137.78% | 9.01B | |
| +1.52% | +0.39% | +48.79% | -5.82% | 6.99B | |
| -0.17% | -2.92% | +13.13% | +30.45% | 6.7B | |
| -0.59% | -1.95% | +2.23% | +178.07% | 6.42B | |
| -7.92% | -13.61% | -34.97% | -4.08% | 5.3B | |
| Average | +3.63% | -2.12% | +16.87% | +71.04% | 15.77B | |
| Weighted average by Cap. | +0.12% | -0.45% | +25.35% | +81.36% |
| 2009 | 2010 | |
|---|---|---|
| Net sales | 57.82M 50.79M 47.23M 43.34M 81.43M 5.57B 82.69M 561M 219M 2.74B 217M 212M 9.47B | 72.7M 63.85M 59.38M 54.49M 102M 7B 104M 705M 275M 3.44B 273M 267M 11.9B |
| Net income | 16.43M 14.43M 13.42M 12.32M 23.14M 1.58B 23.5M 159M 62.27M 778M 61.69M 60.36M 2.69B | 14.42M 12.67M 11.78M 10.81M 20.31M 1.39B 20.63M 140M 54.66M 683M 54.15M 52.98M 2.36B |
| Net Debt | 5.29 4.65 4.32 3.97 7.46 509.8 7.57 51.35 20.06 250.64 19.87 19.44 866.58 | 4.65 4.08 3.8 3.48 6.54 447.49 6.64 45.07 17.61 220 17.44 17.07 760.65 |
Employees
-
Sector
Pharmaceuticals
